文献速递复苏、休克与脓毒症消化、代谢与肾脏急症重症综合管理与镇静镇痛

脓毒性休克患者补充硫胺素:两项随机试验的事后分析

Thiamine administration in septic shock: a post hoc analysis of two randomized trials.
PubMed 文献 · Crit Care · 2024-02-06
一句话结论两项随机试验的事后分析显示,脓毒性休克患者补充硫胺素与出院时存活且未接受肾脏替代治疗(RRT)的几率更高相关(aOR 2.05,95%CI 1.08-3.90),在硫胺素缺乏(<8 nmol/L)者中此关联更强(aOR 8.17,95%CI 1.79-37.22)。

本研究合并两项既往II期临床试验(NCT01070810、NCT03550794)的患者级数据,共纳入158例脓毒性休克患者,评估硫胺素给药对肾脏保护及病死率的影响。主要结局为出院时存活且未接受肾脏替代治疗(RRT)。总体人群中,硫胺素给药与存活且未接受RRT的几率更高相关(aOR 2.05,95%CI 1.08-3.90),与无需RRT的几率更高相关(aOR 2.59,95%CI 1.01-6.62)。在硫胺素缺乏(<8 nmol/L)组中,硫胺素给药与存活且未接受RRT(aOR 8.17,95%CI 1.79-37.22)及存活至出院(aOR 6.84,95%CI 1.54-30.36)的几率更高相关,且基线硫胺素缺乏对上述结局存在显著效应修饰(交互作用p=0.016和p=0.019)。

要点

  • 在两项随机试验合并的158例脓毒性休克患者中,硫胺素给药与出院时存活且未接受RRT的几率更高相关(aOR 2.05,95%CI 1.08-3.90)。
  • 总体人群中,硫胺素给药与无需RRT的几率更高相关(aOR 2.59,95%CI 1.01-6.62)。
  • 在硫胺素缺乏(<8 nmol/L)患者中,硫胺素给药与存活且未接受RRT的几率更高相关(aOR 8.17,95%CI 1.79-37.22)。
  • 在硫胺素缺乏患者中,硫胺素给药与存活至出院的几率更高相关(aOR 6.84,95%CI 1.54-30.36)。
  • 基线硫胺素缺乏对存活且未接受RRT(交互作用p=0.016)和存活至出院(交互作用p=0.019)存在显著效应修饰。

适用人群与场景

  • 两项既往II期临床试验(NCT01070810、NCT03550794)合并队列中的脓毒性休克患者,共158例。

诊断标准与关键阈值

  • 硫胺素缺乏定义为基线硫胺素<8 nmol/L。

研究设计与关键结果

  • 研究类型:两项随机试验(硫胺素在脓毒性休克试验NCT01070810和硫胺素用于脓毒性休克肾脏保护试验NCT03550794)的事后分析,合并患者级数据,共158例。
  • 总体人群中,硫胺素给药与存活且未接受RRT的几率更高相关(aOR 2.05,95%CI 1.08-3.90),与无需RRT的几率更高相关(aOR 2.59,95%CI 1.01-6.62)。
  • 在硫胺素缺乏(<8 nmol/L)组中,硫胺素给药与存活且未接受RRT的几率更高相关(aOR 8.17,95%CI 1.79-37.22),与存活至出院的几率更高相关(aOR 6.84,95%CI 1.54-30.36)。
  • 基线硫胺素缺乏对存活且未接受RRT存在显著效应修饰(交互作用p=0.016),对存活至出院存在显著效应修饰(交互作用p=0.019)。

证据类型、等级与局限

  • 证据类型:两项随机试验的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在两项既往随机试验的合并分析中,硫胺素给药与脓毒性休克患者出院时存活且未接受RRT的几率更高相关,此信号在硫胺素缺乏患者中更强。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: This is a post hoc analysis of combined cohorts from two previous Phase II clinical trials to assess the effect of thiamine administration on kidney protection and mortality in patients with septic shock.

METHODS: Patient-level data from the Thiamine in Septic Shock Trial (NCT01070810) and the Thiamine for Renal Protection in Septic Shock Trial (NCT03550794) were combined in this analysis. The primary outcome for the current study was survival without the receipt of renal replacement therapy (RRT). Analyses were performed on the overall cohort and the thiamine-deficient cohort (thiamine < 8 nmol/L).

RESULTS: Totally, 158 patients were included. Overall, thiamine administration was associated with higher odds of being alive and RRT-free (adjusted odds ratio [aOR]: 2.05 [95% confidence interval (CI) 1.08-3.90]) and not needing RRT (aOR: 2.59 [95% CI 1.01-6.62]). In the thiamine-deficient group, thiamine administration was associated with higher odds of being alive and RRT-free (aOR: 8.17 [95% CI 1.79-37.22]) and surviving to hospital discharge (aOR: 6.84 [95% CI 1.54-30.36]). There was a significant effect modification by baseline thiamine deficiency for alive and RRT-free (interaction, p = 0.016) and surviving to hospital discharge (p = 0.019).

CONCLUSION: In the combined analysis of two previous randomized trials, thiamine administration was associated with higher odds of being alive and RRT-free at hospital discharge in patients with septic shock. This signal was stronger in patients with thiamine deficiency.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Vine J, Lee JH, Kravitz MS, et al. Thiamine administration in septic shock: a post hoc analysis of two randomized trials. Crit Care. 2024. PMID: 38321529. doi:10.1186/s13054-024-04818-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。